PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
11-Apr-2024 VieCure Streamlines Cancer Care by Adding E-Prescribing Solutions from DrFirst DrFirst
11-Apr-2024 Powered Wheelchair Market Size To Reach $3.21 Billion By 2030 Grand View Research, Inc.
11-Apr-2024 AbbVie’s AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults AbbVie
11-Apr-2024 Warmer UK climate triggers early allergy alerts and brings the threat of new pollens London Medical Laboratory
09-Apr-2024 Green Elephant Biotech expands sustainable 96-well plate line for light-sensitive experiments Green Elephant Biotech
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead Sciences, Inc
09-Apr-2024 EpiBiologics Extracellular Protein Degraders Demonstrate Robust Preclinical Anti-tumor Activity and Survival Benefit EpiBiologics
09-Apr-2024 PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions PureTech Health plc
09-Apr-2024 Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD Lundbeck
09-Apr-2024 OMRON Healthcare Acquires Luscii Healthtech to Advance and Innovate Remote Patient-monitoring Adoption at Scale OMRON Healthcare
09-Apr-2024 OncoZenge Appoints Åsa Nilsson as Clinical Research Manager OncoZenge
09-Apr-2024 Exploring the Global Endoscopy Equipment Market: Key Players and Strategies Markets and Markets
09-Apr-2024 Companion Diagnostics: Tailoring Treatment for Individual Patients Markets and Markets
08-Apr-2024 Mersey and West Lancashire Teaching Hospitals NHS Trust Teams Up with Netcall to Transform Patient Engagement with Cutting-Edge Digital Solutions Mersey and West Lancashire Teaching Hospitals NHS Trust
08-Apr-2024 OncoZenge Announces Dr. Paolo Bossi as New Member of the Advisory Board OncoZenge
08-Apr-2024 Medicxi Announces $40m investment in D3 Bio Medicxi
08-Apr-2024 Idorsia’s QUVIVIQ™▼ (daridorexant) accepted for restricted use within NHS Scotland to treat insomnia Idorsia UK Ltd
08-Apr-2024 InnoScot Health spinout looks to further catalyse growth with London conference slot InnoScot Health
08-Apr-2024 Scottish Medicines Consortium (SMC) accepts Camzyos®▼(mavacamten) for use on the NHS as an adjunct treatment option for adults with symptomatic obstructive hypertrophic cardiomyopathy Bristol Myers Squibb
08-Apr-2024 World Health Day ‘champions right of all to quality care – and innovation can further bridge the gap’ InnoScot Health